← Back to headlines
Amgen announces positive late-stage results for subcutaneous Tepezza
Amgen reported positive late-stage clinical trial results for its subcutaneous drug, Tepezza, indicating promising developments for its efficacy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
HEAT INDEX WATCH as of April 6, 2026: Danger level in 3 areas
just now
Ghanaian MP Samuel Okudzeto Ablakwa settles medical bills for 85 constituents
6m ago
Husband released after 27-year-old woman jumps from 4th floor in Marousi, Greece
7m ago
Sofia Kourtidou discusses body image, eating disorders, and relationship
18m ago